a modification to the pre-treatment reagent , consisting of a threefold increase in concentration and the addition of 1 mol/l urea , is proposed which enables either plasma or serum to be used , reduces the bias and eliminates the interference caused by hemolysis .
C0032105
plasma
C0229671
serum